Effectiveness of Short-Course Meglumine Antimoniate (Glucantime(®)) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran

The World Health Organization's (WHO) recommendation is 28-day course of meglumine antimoniate (Glucantime(®), Sanofi Aventis, France) for the treatment of visceral leishmaniasis (VL). The aim of this study was to evaluate the effectiveness of a shorter duration of treatment in regions with low...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Trop Med Hyg
Prif Awduron: Alborzi, Abdolvahab, Pouladfar, Gholamreza, Attar, Armin, Falahi, Fatemeh, Jafarpour, Zahra, Karimi, Abdollah, Kadivar, Mohammad Rahim
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The American Society of Tropical Medicine and Hygiene 2017
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5239690/
https://ncbi.nlm.nih.gov/pubmed/27879460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.16-0345
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg